VolitionRX Ltd To Present At GCFF Transcript
We are VolitionRX. Ticker is BNRX on the New York Stock Exchange, American Stock Exchange. I will be making some forward-looking statements. So I do point you to the forward-looking statements and disclaimer. And a little bit about Volition. Volition is simple. We want to save lives.
We are a diagnostics company, developing blood tests to screen primarily for different cancer types. But As Gilbert mentioned, we are also developing a blood test for a noncancer indication [of] COVID-19. And I'll talk a little bit about that product because the coronavirus is front and center for most of us these days.
So here, you can see a little bit about our COVID-19 product development, developing a blood tests for this particular virus. We are not developing a frontline blood test for the coronavirus. There are a number of FDA approved frontline screens for the coronavirus already in use in the United States.
What we are planning to develop is a triage or a risk stratification blood test to be given to patients who have had a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
